A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment
Clinical trial NCT03713242 · COMPLETED
Trial details
- NCT number
- NCT03713242
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2020-02-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.